Validation and Standardization of Test Methods and Evaluators for Testing of Hair Care Range of Products

NCT ID: NCT05763888

Last Updated: 2023-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-12

Study Completion Date

2023-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An exploratory approach for validation and standardization of test methods and evaluators to conduct In-Vivo clinical safety and efficacy testing of hair care range of products.

A total of 40 subjects will be enrolled.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an internal standardization and validation study. This standardization and validation study will be carried out by the trainee evaluators' of NovoBliss Research who voluntarily wish to take part in this study. There are multiple techniques for establishing documentary evidence demonstrating that standardised procedural steps, processes and methods are carried out in testing for hairs care range of products to maintain the desired level of compliance.

It is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results. The desired results are established in terms of specifications for the outcome of the processes.

Below listed test methods/techniques will be performed:

* Assessment of General appearance of hair (i.e. Hair Volume, Hair Density, Hair Reflection, Hair Plasticity, Hair Smoothness, Hair Oiliness, Shininess)
* Assessment of Scalp Appearance i.e. itchiness, dryness, redness, roughness, and scaliness of scalp
* Assessment of Adherent Scalp Flaking Score (ASFS)
* Assessment of Hair Strength (i.e. Poor, Average, Good)
* Assessment of Gray Hair - Graying Severity Score (GSS); Hair Whitening Score. Evaluation Methods
* 60-seconds hair count (Hair Combing Method)
* Hair Pull Test
* Trichogram (Pluck Test - Anagen: Telogen Ratio Calculation)
* Scanning Electron Microscope (SEM)

Instrumental Evaluation:

* Phototrichogram - Tattoo Method for Hair Growth Rate, Hair Density, Hair Thickness, and Scalp Condition i.e. Scalp Dandruff - Using CASLite Nova
* Scalp Hydration by MoistureMeterEpiD
* Scalp Sebum level by Sebumeter
* Hair Color by Hair/Skin Colorimeter CL 410
* Image analysis for Hair Growth Rates, number of hairs and length, and Gray hair counts, using Image-Pro Software
* Assessment of Hair Cuticle - by Electron microscope to check parameters such as surface damage of hair, photodamage of outermost cuticle layer
* Microbial changes in scalp flora by trichoscopy or dermoscopy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Subject

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No drug will given

No intervention will be given to the subject

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age: 18 - 75 years (both inclusive) at the time of consent.
2. Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females).
3. Females of childbearing potential must have a self-reported negative urine pregnancy.
4. Subject is in good general health as determined by the Investigator on the basis of medical history.
5. Subject is willing and able to follow and allow study staff to performed study test methods
6. Subject is willing and able to follow the study directions, to participate in the study, returning for all specified visits.
7. Subject must be able to understand and provide written informed consent to participate in the study.

Exclusion Criteria

1. Subject have history of allergy to any ink.
2. Subject have participated any clinical research study related to hair care products.
3. Subject having history of diabetes
4. Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.
5. Subject having known history of any skin diseases including eczema, atopic dermatitis or active cancer.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NovoBliss Research Pvt Ltd

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Maheshvari Patel

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr. Nayan K Patel, MBBS

Role: STUDY_DIRECTOR

Medical Director

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NovoBliss Research Pvt Ltd

Gandhinagar, Gujarat, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NB220039-NB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.